Global Metabotropic Glutamate Receptor 7 Market Insights, Forecast To 2028

1 Study Coverage
1.1 Metabotropic Glutamate Receptor 7 Product Introduction
1.2 Market by Type
1.2.1 Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 JBPOS-0101
1.2.3 PGT-117
1.2.4 ADX-71743
1.2.5 Others
1.3 Market by Application
1.3.1 Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Generalized Anxiety Disorder
1.3.3 Infantile Spasm
1.3.4 Status Epilepticus
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Metabotropic Glutamate Receptor 7 Sales Estimates and Forecasts 2017-2028
2.2 Global Metabotropic Glutamate Receptor 7 Revenue Estimates and Forecasts 2017-2028
2.3 Global Metabotropic Glutamate Receptor 7 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Metabotropic Glutamate Receptor 7 Sales by Region
2.4.1 Global Metabotropic Glutamate Receptor 7 Sales by Region (2017-2022)
2.4.2 Global Sales Metabotropic Glutamate Receptor 7 by Region (2023-2028)
2.5 Global Metabotropic Glutamate Receptor 7 Revenue by Region
2.5.1 Global Metabotropic Glutamate Receptor 7 Revenue by Region (2017-2022)
2.5.2 Global Metabotropic Glutamate Receptor 7 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Metabotropic Glutamate Receptor 7 Sales by Manufacturers
3.1.1 Global Top Metabotropic Glutamate Receptor 7 Manufacturers by Sales (2017-2022)
3.1.2 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metabotropic Glutamate Receptor 7 in 2021
3.2 Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturers
3.2.1 Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturers (2017-2022)
3.2.2 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 7 Revenue in 2021
3.3 Global Metabotropic Glutamate Receptor 7 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Metabotropic Glutamate Receptor 7 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Metabotropic Glutamate Receptor 7 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metabotropic Glutamate Receptor 7 Sales by Type
4.1.1 Global Metabotropic Glutamate Receptor 7 Historical Sales by Type (2017-2022)
4.1.2 Global Metabotropic Glutamate Receptor 7 Forecasted Sales by Type (2023-2028)
4.1.3 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
4.2 Global Metabotropic Glutamate Receptor 7 Revenue by Type
4.2.1 Global Metabotropic Glutamate Receptor 7 Historical Revenue by Type (2017-2022)
4.2.2 Global Metabotropic Glutamate Receptor 7 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
4.3 Global Metabotropic Glutamate Receptor 7 Price by Type
4.3.1 Global Metabotropic Glutamate Receptor 7 Price by Type (2017-2022)
4.3.2 Global Metabotropic Glutamate Receptor 7 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 7 Sales by Application
5.1.1 Global Metabotropic Glutamate Receptor 7 Historical Sales by Application (2017-2022)
5.1.2 Global Metabotropic Glutamate Receptor 7 Forecasted Sales by Application (2023-2028)
5.1.3 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
5.2 Global Metabotropic Glutamate Receptor 7 Revenue by Application
5.2.1 Global Metabotropic Glutamate Receptor 7 Historical Revenue by Application (2017-2022)
5.2.2 Global Metabotropic Glutamate Receptor 7 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
5.3 Global Metabotropic Glutamate Receptor 7 Price by Application
5.3.1 Global Metabotropic Glutamate Receptor 7 Price by Application (2017-2022)
5.3.2 Global Metabotropic Glutamate Receptor 7 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Metabotropic Glutamate Receptor 7 Market Size by Type
6.1.1 North America Metabotropic Glutamate Receptor 7 Sales by Type (2017-2028)
6.1.2 North America Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2028)
6.2 North America Metabotropic Glutamate Receptor 7 Market Size by Application
6.2.1 North America Metabotropic Glutamate Receptor 7 Sales by Application (2017-2028)
6.2.2 North America Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2028)
6.3 North America Metabotropic Glutamate Receptor 7 Market Size by Country
6.3.1 North America Metabotropic Glutamate Receptor 7 Sales by Country (2017-2028)
6.3.2 North America Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 7 Market Size by Type
7.1.1 Europe Metabotropic Glutamate Receptor 7 Sales by Type (2017-2028)
7.1.2 Europe Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2028)
7.2 Europe Metabotropic Glutamate Receptor 7 Market Size by Application
7.2.1 Europe Metabotropic Glutamate Receptor 7 Sales by Application (2017-2028)
7.2.2 Europe Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2028)
7.3 Europe Metabotropic Glutamate Receptor 7 Market Size by Country
7.3.1 Europe Metabotropic Glutamate Receptor 7 Sales by Country (2017-2028)
7.3.2 Europe Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Metabotropic Glutamate Receptor 7 Market Size by Type
8.1.1 Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Type (2017-2028)
8.1.2 Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2028)
8.2 Asia Pacific Metabotropic Glutamate Receptor 7 Market Size by Application
8.2.1 Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Application (2017-2028)
8.2.2 Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2028)
8.3 Asia Pacific Metabotropic Glutamate Receptor 7 Market Size by Region
8.3.1 Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Region (2017-2028)
8.3.2 Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Metabotropic Glutamate Receptor 7 Market Size by Type
9.1.1 Latin America Metabotropic Glutamate Receptor 7 Sales by Type (2017-2028)
9.1.2 Latin America Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2028)
9.2 Latin America Metabotropic Glutamate Receptor 7 Market Size by Application
9.2.1 Latin America Metabotropic Glutamate Receptor 7 Sales by Application (2017-2028)
9.2.2 Latin America Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2028)
9.3 Latin America Metabotropic Glutamate Receptor 7 Market Size by Country
9.3.1 Latin America Metabotropic Glutamate Receptor 7 Sales by Country (2017-2028)
9.3.2 Latin America Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Type
10.1.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2028)
10.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Application
10.2.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2028)
10.3 Middle East and Africa Metabotropic Glutamate Receptor 7 Market Size by Country
10.3.1 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Corporation Information
11.1.2 Addex Therapeutics Ltd Overview
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Addex Therapeutics Ltd Recent Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Corporation Information
11.2.2 Aevi Genomic Medicine Inc Overview
11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aevi Genomic Medicine Inc Recent Developments
11.3 Bio-Pharm Solutions Co Ltd
11.3.1 Bio-Pharm Solutions Co Ltd Corporation Information
11.3.2 Bio-Pharm Solutions Co Ltd Overview
11.3.3 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bio-Pharm Solutions Co Ltd Recent Developments
11.4 Pragma Therapeutics SAS
11.4.1 Pragma Therapeutics SAS Corporation Information
11.4.2 Pragma Therapeutics SAS Overview
11.4.3 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pragma Therapeutics SAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Metabotropic Glutamate Receptor 7 Industry Chain Analysis
12.2 Metabotropic Glutamate Receptor 7 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metabotropic Glutamate Receptor 7 Production Mode & Process
12.4 Metabotropic Glutamate Receptor 7 Sales and Marketing
12.4.1 Metabotropic Glutamate Receptor 7 Sales Channels
12.4.2 Metabotropic Glutamate Receptor 7 Distributors
12.5 Metabotropic Glutamate Receptor 7 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Metabotropic Glutamate Receptor 7 Industry Trends
13.2 Metabotropic Glutamate Receptor 7 Market Drivers
13.3 Metabotropic Glutamate Receptor 7 Market Challenges
13.4 Metabotropic Glutamate Receptor 7 Market Restraints
14 Key Findings in The Global Metabotropic Glutamate Receptor 7 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of JBPOS-0101
Table 3. Major Manufacturers of PGT-117
Table 4. Major Manufacturers of ADX-71743
Table 5. Major Manufacturers of Others
Table 6. Global Metabotropic Glutamate Receptor 7 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Metabotropic Glutamate Receptor 7 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Metabotropic Glutamate Receptor 7 Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2017-2022)
Table 10. Global Metabotropic Glutamate Receptor 7 Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2023-2028)
Table 12. Global Metabotropic Glutamate Receptor 7 Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2017-2022)
Table 14. Global Metabotropic Glutamate Receptor 7 Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2023-2028)
Table 16. Global Metabotropic Glutamate Receptor 7 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Metabotropic Glutamate Receptor 7 Sales Share by Manufacturers (2017-2022)
Table 18. Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Metabotropic Glutamate Receptor 7 Revenue Share by Manufacturers (2017-2022)
Table 20. Metabotropic Glutamate Receptor 7 Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Metabotropic Glutamate Receptor 7 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Metabotropic Glutamate Receptor 7 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 7 as of 2021)
Table 23. Metabotropic Glutamate Receptor 7 Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Metabotropic Glutamate Receptor 7 Product Offered
Table 25. Date of Manufacturers Enter into Metabotropic Glutamate Receptor 7 Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Metabotropic Glutamate Receptor 7 Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Metabotropic Glutamate Receptor 7 Sales Share by Type (2017-2022)
Table 30. Global Metabotropic Glutamate Receptor 7 Sales Share by Type (2023-2028)
Table 31. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Metabotropic Glutamate Receptor 7 Revenue Share by Type (2017-2022)
Table 34. Global Metabotropic Glutamate Receptor 7 Revenue Share by Type (2023-2028)
Table 35. Metabotropic Glutamate Receptor 7 Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Metabotropic Glutamate Receptor 7 Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Metabotropic Glutamate Receptor 7 Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Metabotropic Glutamate Receptor 7 Sales Share by Application (2017-2022)
Table 40. Global Metabotropic Glutamate Receptor 7 Sales Share by Application (2023-2028)
Table 41. Global Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Metabotropic Glutamate Receptor 7 Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Metabotropic Glutamate Receptor 7 Revenue Share by Application (2017-2022)
Table 44. Global Metabotropic Glutamate Receptor 7 Revenue Share by Application (2023-2028)
Table 45. Metabotropic Glutamate Receptor 7 Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Metabotropic Glutamate Receptor 7 Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Metabotropic Glutamate Receptor 7 Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Metabotropic Glutamate Receptor 7 Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Metabotropic Glutamate Receptor 7 Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Metabotropic Glutamate Receptor 7 Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Metabotropic Glutamate Receptor 7 Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Metabotropic Glutamate Receptor 7 Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Metabotropic Glutamate Receptor 7 Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Metabotropic Glutamate Receptor 7 Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Metabotropic Glutamate Receptor 7 Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Metabotropic Glutamate Receptor 7 Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Metabotropic Glutamate Receptor 7 Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Metabotropic Glutamate Receptor 7 Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Metabotropic Glutamate Receptor 7 Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Metabotropic Glutamate Receptor 7 Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Metabotropic Glutamate Receptor 7 Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Metabotropic Glutamate Receptor 7 Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue by Country (2023-2028) & (US$ Million)
Table 107. Addex Therapeutics Ltd Corporation Information
Table 108. Addex Therapeutics Ltd Description and Major Businesses
Table 109. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Addex Therapeutics Ltd Recent Developments
Table 112. Aevi Genomic Medicine Inc Corporation Information
Table 113. Aevi Genomic Medicine Inc Description and Major Businesses
Table 114. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Aevi Genomic Medicine Inc Recent Developments
Table 117. Bio-Pharm Solutions Co Ltd Corporation Information
Table 118. Bio-Pharm Solutions Co Ltd Description and Major Businesses
Table 119. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Bio-Pharm Solutions Co Ltd Recent Developments
Table 122. Pragma Therapeutics SAS Corporation Information
Table 123. Pragma Therapeutics SAS Description and Major Businesses
Table 124. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pragma Therapeutics SAS Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Metabotropic Glutamate Receptor 7 Distributors List
Table 130. Metabotropic Glutamate Receptor 7 Customers List
Table 131. Metabotropic Glutamate Receptor 7 Market Trends
Table 132. Metabotropic Glutamate Receptor 7 Market Drivers
Table 133. Metabotropic Glutamate Receptor 7 Market Challenges
Table 134. Metabotropic Glutamate Receptor 7 Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 7 Product Picture
Figure 3. Global Metabotropic Glutamate Receptor 7 Market Share by Type in 2021 & 2028
Figure 3. JBPOS-0101 Product Picture
Figure 4. PGT-117 Product Picture
Figure 5. ADX-71743 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Metabotropic Glutamate Receptor 7 Market Share by Application in 2021 & 2028
Figure 8. Generalized Anxiety Disorder
Figure 9. Infantile Spasm
Figure 10. Status Epilepticus
Figure 11. Others
Figure 12. Metabotropic Glutamate Receptor 7 Report Years Considered
Figure 13. Global Metabotropic Glutamate Receptor 7 Sales 2017-2028 (K Pcs)
Figure 14. Global Metabotropic Glutamate Receptor 7 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Metabotropic Glutamate Receptor 7 Revenue 2017-2028 (US$ Million)
Figure 16. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2017-2022)
Figure 18. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2023-2028)
Figure 19. North America Metabotropic Glutamate Receptor 7 Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Metabotropic Glutamate Receptor 7 Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Metabotropic Glutamate Receptor 7 Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Metabotropic Glutamate Receptor 7 Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Metabotropic Glutamate Receptor 7 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Metabotropic Glutamate Receptor 7 Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Metabotropic Glutamate Receptor 7 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Metabotropic Glutamate Receptor 7 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Metabotropic Glutamate Receptor 7 in the World: Market Share by Metabotropic Glutamate Receptor 7 Revenue in 2021
Figure 31. Global Metabotropic Glutamate Receptor 7 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
Figure 33. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
Figure 34. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
Figure 35. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
Figure 36. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
Figure 37. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
Figure 38. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
Figure 39. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
Figure 40. North America Metabotropic Glutamate Receptor 7 Sales Share by Country (2017-2028)
Figure 41. North America Metabotropic Glutamate Receptor 7 Revenue Share by Country (2017-2028)
Figure 42. U.S. Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
Figure 45. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
Figure 46. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
Figure 47. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
Figure 48. Europe Metabotropic Glutamate Receptor 7 Sales Share by Country (2017-2028)
Figure 49. Europe Metabotropic Glutamate Receptor 7 Revenue Share by Country (2017-2028)
Figure 50. Germany Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 51. France Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Metabotropic Glutamate Receptor 7 Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Metabotropic Glutamate Receptor 7 Revenue Share by Region (2017-2028)
Figure 61. China Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 64. India Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
Figure 72. Latin America Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
Figure 74. Latin America Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Metabotropic Glutamate Receptor 7 Sales Share by Country (2017-2028)
Figure 76. Latin America Metabotropic Glutamate Receptor 7 Revenue Share by Country (2017-2028)
Figure 77. Mexico Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Share by Country (2017-2028)
Figure 86. Turkey Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Metabotropic Glutamate Receptor 7 Revenue (2017-2028) & (US$ Million)
Figure 89. Metabotropic Glutamate Receptor 7 Value Chain
Figure 90. Metabotropic Glutamate Receptor 7 Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.